Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.

Slides:



Advertisements
Similar presentations
Living well with dementia: more timely diagnosis and early intervention Louise Robinson Professor of Primary Care and Ageing RCGP National Clinical Champion.
Advertisements

New England Journal of Medicine October 18;367: Relapse Risk after Discontinuation of Risperidone in Alzheimer’s disease Molly Moncrieff.
Epidemiological study of mild cognitive impairment and pilot evaluation of methods of early dementia detection in Chinese community Yueqin Huang MD MPH.
Health Impacts of Caregiving: FINDINGS FROM THE SINGAPORE INFORMAL CARE SURVEY Authors: Angelique Chan, Chetna Malhotra, Rahul Malhotra, Truls Ostbye Institution:
MemTrax (Computerized Memory Screen) American Association of Geriatric Psychiatry (AAGP) March 2, 2007 J. Wesson Ashford, M.D., Ph.D. Stanford / VA Aging.
PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,
Assessment/Enhancement of Cognitive Ability in Older Adults Karlene Ball Center for Research on Applied Gerontology University of Alabama at Birmingham.
Brief Cognitive Assessment Tool (BCAT®) Training Program
Tony WAEGEMANS, MD UCB Pharma, Belgium. TW/ll/ Washington/MCI 2 MCI as implemented in our study MCI is a very early stage of dementia with as main.
Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in Gaza strip: a cross-sectional study By: Ashraf Eljedi:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Functional Assessment Adam Burrows, MD Boston University Geriatrics Section Copyright Boston University Medical Center.
Mary Ganguli’s Slides March 13 th Meeting. Mild Cognitive Impairment A View from the Trenches.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Health Economics and Technology Assessment Research Centre Katalin Érsek 1, Krisztián Kárpáti 1, Tibor Kovács 2, László Gulácsi.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
COGNITIVE APPROACHES TO SUICIDE Center for Disease Control and Prevention February 6, 2004 Aaron T. Beck, M.D. Gregory K. Brown, Ph.D. University of Pennsylvania.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Challenges Assessing Functional Outcomes in Early Huntington Disease Jane Paulsen 1, Chiachi Wang 1, Kevin Duff 1, Roger Barker 2, Martha Nance 3, Leigh.
Overview of Phase I Data: Approach and Findings Gary Bess Associates April 15, 2009.
Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under.
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice Dea Kehler.
Are There Sex Differences in sociodemographic background and cognitive Functions Among Patients With dementia,a comparative study among an Egyptian sample.
1 Patient Dependence, Function, and Changes in Cost of Care in Alzheimer’s Disease Carolyn W. Zhu JJP VA Medical Center, Mount Sinai School of Medicine.
Perceived Recovery as a Predictor of Physical Activity after Mild Stroke Jessica Koster, BA, MSOTS 1, & Timothy J. Wolf, OTD, MSCI, OTR/L 1,2 Washington.
Fibromyalgia Patients Reading Self-Help Journals and in Internet Self-Help Groups: Are They Different from Patients in Clinical Practice? Robert Katz 1,
WHAT WE LEARNED In a clinically-referred, assisted living sample: 1.NAB Judgment (NAB-JDG) scores displayed good internal consistency reliability. 2.NAB-JDG.
Delusions, behavioural symptoms, quality of life and caregiver effects in AD Delusions, behavioural symptoms, quality of life and caregiver effects in.
Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology.
Meredith Cook – PharmD Candidate Mercer University COPHS August, 2012 Cognitive Trajectories after Postoperative Delirium.
Lecture 6: Reliability and validity of scales (cont) 1. In relation to scales, define the following terms: - Content validity - Criterion validity (concurrent.
Copyright restrictions may apply Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents: A 2-Year Prospective Study Ko C-H, Yen.
Table 2: Correlation between age and readiness to change Table 1: T-test relating gender and readiness to change  It is estimated that 25% of children.
Farid Najafi MD PhD School of Public Health Kermanshah University of Medical Sciences Health status of the elderly population of Iran in 2012.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Relational Discord at Conclusion of Treatment Predicts Future Substance Use for Partnered Patients Wayne H. Denton, MD, PhD; Paul A. Nakonezny, PhD; Bryon.
How To Design a Clinical Trial
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
Printed by Natural History of Sun Protection Behaviors in a Cohort of Children in Colorado Nancy L. Asdigian PhD,* Lori A. Crane.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Cognitive Testing, Statistics and Dementia Ralph J. Kiernan Ph.D. 14 th May 2013.
Comparison of Risk Factors for Early-Onset versus Late-Onset Alzheimer Disease OBJECTIVE To compare early-onset (before 65) Alzheimer disease (AD) patients.
Biomedical Research Centre for Mental Health and Dementia Unit at South London and Maudsley NHS Foundation Trust the Institute of Psychiatry, King’s College.
The status of understanding Dementia and Living Environment of Korean elderly population Eun-Ah Lee, MD., Eun Hyang Song, MD., Joon Young Lee *, MD Department.
DIABETES AS A RISK FACTOR FOR COGNITIVE DECLINE IN OLDER PATIENTS F. Limongi, A. Marseglia, S. Maggi, M. Noale, G. Romanato, P. Siviero, G. Crepaldi CNR,
Association of Cognitive Outcomes and Response Status in Late Life Depression: A 12 Month Longitudinal Study David Bickford B.A., Alana Kivowitz B.A.,
Clinicaloptions.com/hepatitis NAFLD and NASH Prevalence in US Cohort Slideset on: Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty.
Vanderbilt Sports Medicine Sports Concussion Assessment Tool An Update and Systematic Review David G. Liddle, MD Assistant Professor of Orthopedics Assistant.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Update on Frailty Assessment in Older Patients with Aortic Stenosis Dr Amy Jones ST5/Clinical Research Fellow Geriatric Medicine.
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
ABSTRACT Purpose: Many experiences in late-life may contribute to depression, but some older adults appear more vulnerable than others. We investigated.
Association of Body Mass Index (BMI) and Depression Severity
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
Provider-Caregiver Interactions: Evaluation and Use of the Therapeutic Relationship Index for Caregiver Interventions Yeon Kyung Chee, Marie P. Dennis,
Jen Yates, Linda Clare, Bob Woods and CFAS Wales
TEXILA AMERICAN UNIVERSITY
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
How Neurological Disability Influences the Quality of Life in People With Multiple Sclerosis Luísa Pedro / José Luís Pais Ribeiro Escola Superior de Tecnologia.
Table 1. Summary of Study Measures
Subjective memory complaints, mood and MCI: A follow-up study
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Epidemiology of Dementia: the MoVIES Project
INTERPRETATION OF RESULTS & CONCLUSIONS
Monday, 17 September 2018 Should capacity assessment be performed routinely prior to discussing advance care planning with older people? Oleg Kiriaev,
Dr. Muhammad Ajmal Zahid Chairman, Department of Psychiatry,
Rhematoid Rthritis Respiratory disorders
Clinical Presentation
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Presentation transcript:

Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic Criteria for Predementia Alzheimer’s Disease Study Sietske A. M. Sikkes, PhD, Pieter Jelle Visser, MD, PhD, Dirk L. Knol, PhD, et al. JAGS; December 2011, vol 59, No. 12 Payal Patel Mercer University, College of Pharmacy and Health Sciences RTR Medical Group 1/31/2012

Background & study purpose Dementia is the most common disease in later life Diagnosis is based on decline in scales that assess disabilities in activities of daily living (ADLs) ADL refers to basic activity of daily living (BADL) and instrumental activities of daily living (IADL) Complex activities are more sensitive to cognitive decline in early stages of dementia IADL assessment can play an important role in screening/diagnosing dementia

Background & study purpose Several studies have investigated the use of IADL scales in diagnosing dementia Previous studies showed variable results from no correlation to strong association Difficult to compare because the selection of items and participants vary This study investigates whether interference in IADLs can predict dementia at 1 and 2 year follow-up in a memory clinic setting

Study Design and Population Prospective cohort study Participants selected from DESCRIPA study which was done by the European Alzheimer’s Disease Consortium Participants recruited from 20 memory clinics across Europe between January 2003 and June 2005

Study Design and Population Inclusion Criteria: Age 55 and older with a new referral due to cognitive complaints Exclusion Criteria: patients with cognitive impairment due to somatic, psychiatric or neurological disorder

Outcome Measures Instrumental Activities of Daily Living Different IADL scales were used between the study centers: 16 centers used an IADL scale 9 used Lawton IADL scale 3 used Blessed Dementia scale and Bayer ADL scale 1 used Alzheimer’s Disease Cooperative study ADL scale 1 used Bristol ADL scale

Primary outcome All questionnaires completed by informant of the participant Items related to IADLs were chosen from the questionnaires Item content that overlapped between the different tests was selected to pool IADLs Responses were dichotomized to ‘no problems’ or ‘slight to severe problems’

Outcome Measures Cognitive Examination – MMSE – Memory tests – Varied between the centers Primarily Rey Auditory Verbal Learning Test – Depression Different scales between the centers Scores dichotomized for clinically significant depressive symptoms in each of the scales

Statistical method Statistical analysis were performed using M- Plus version 6.1 and SPSS Differences between participants with and without dementia were analyzed with independent t tests or chi square

Statistical methods Item response theory was used to model the dimensional structure of IADLs The relationship between IADL and the diagnosis of dementia, depression, and memory were modeled using SEM P<0.05 was considered statistically significant

Results sample size = 616 participants 1 st year = nd year = 481 Nine items were chosen: shopping, telephone use, housekeeping, transport, finances, medication, food/drink preparation, laundry, handling money 13 % developed dementia in 1 year with most common cause being Alzheimer’s 20.8 % patients had developed dementia in 2 years

Results Participants with at least one IADL problem had a higher rate of having dementia after 1 year (15.9%) compared to participants without IADL problems (P = 0.04) Participants with IADL disabilities at baseline also had a higher rate of dementia at 2 years (24.4%) compared to participants who did not have IADL problems (P = 0.04)

Results Participants who developed dementia were mostly older (p = 0.02) with lower MMSE scores ( p < 0.001) and greater memory impairments (p < = 0.001) at baseline Depression was not found to be a risk factor for developing dementia

Results CharacteristicN = 531Dementia (n = 69) at 1 year No Dementia (n = 462) at 1 year P value Age, mean +/- SD69.6 +/ / / Female, n (%)315 (59.3)46 (66.7)269 (58.2)0.18 Education, n Primary Secondary >Secondary MMSE score, median (range) 28 (26-29)27 (25-28)28 (27-29)< Memory Z –score, mean +/- SD / / /- 1.32<0.001 Depressed, n (%)50 (10.0)3 (4.4)47 (10.8)0.10

Conclusion IADL disability can be a useful tool in predicting dementia at 1 and 2 year follow-up along with other commonly used clinical measures such as MMSE and memory IADL problems are the border between the preclinical stages of dementia and dementia Depression is not a risk factor for developing dementia

Comments Strengths: – Sample size – Prospective design Weaknesses: – Pooled IADL items from different questionnaires Items might not be closely comparable – Difficult to say which IADL questionnaire should be used – Many patients did not complete the questionnaires completely Limited use in clinical practice – Most of the scales were developed to evaluate patients over time and not for diagnostic purposes Underestimation of the true diagnostic value of IADL problems – In some countries or regions, people may visit a memory clinic later in the disease course compared to others